[Federal Register: September 10, 1998 (Volume 63, Number 175)]
[Notices]               
[Page 48523]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10se98-114]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 5, 1998, and published in the Federal Register 
on May 19, 1998, (63 FR 27589), Novartis Pharmaceuticals Corp., 59 
Route 10, East Hanover, New Jersey 07936, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of methylpenidate (1724), a basic class of controlled 
substance listed in Schedule II.
    The firm plans to manufacture finished product for distribution to 
its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Novartis Pharmaceuticals Corp. to 
manufacture methylpenidate is consistent with the public interest at 
this time. DEA has investigated Novartis Pharmaceuticals Corp. on a 
regular basis to ensure that the company's continued registration is 
consistent with the public interest. These investigations have included 
inspection and testing of the company's physical security systems, 
audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic class 
of controlled substance listed above is granted.

    Dated: September 2, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-24294 Filed 9-9-98; 8:45 am]
BILLING CODE 4410-09-M